Skip to content
Sign in
Artwork for Pharmaceutical Executive
Pharmaceutical Executive · Tuesday · 3 min

Pharmaceutical Executive Daily: Executive Order Reduces Childhood Vaccine Recommendations

In today's Pharmaceutical Executive Daily, a new report finds U.S. rare disease biotech investment rebounding after FDA's Priority Review Voucher program renewal, President Trump signs an executive order narrowing the recommended childhood vaccine schedule, and BeOne Medicines and Revolution Medicines announce a multi-part oncology collaboration.

0:00-3:10
Play in podnod

transcript

No transcript — this publisher did not publish one.

show notes

In today's Pharmaceutical Executive Daily, a new report finds U.S. rare disease biotech investment rebounding after FDA's Priority Review Voucher program renewal, President Trump signs an executive order narrowing the recommended childhood vaccine schedule, and BeOne Medicines and Revolution Medicines announce a multi-part oncology collaboration.

more episodes

All episodes